Management of Multiple Myeloma and Usage of Bortezomib: Perspective from India and Ukraine

about

Management of Multiple Myeloma and Usage of Bortezomib: Perspective from India and Ukraine

Item

http://www.wikidata.org/entity/Q37425782

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Management of Multiple Myeloma ...... pective from India and Ukraine

@en

Management of Multiple Myeloma ...... ective from India and Ukraine.

@nl

type

Item

label

Management of Multiple Myeloma ...... pective from India and Ukraine

@en

Management of Multiple Myeloma ...... ective from India and Ukraine.

@nl

prefLabel

Management of Multiple Myeloma ...... pective from India and Ukraine

@en

Management of Multiple Myeloma ...... ective from India and Ukraine.

@nl

P1476

Management of Multiple Myeloma ...... pective from India and Ukraine

@en

P2093

Amit Garg

http://www.w3.org/2001/XMLSchema#string

India and Ukraine Haemato-oncology Group

http://www.w3.org/2001/XMLSchema#string

Mykhaylo Morgunskyy

http://www.w3.org/2001/XMLSchema#string

Namita Gupta

http://www.w3.org/2001/XMLSchema#string

Shyam Prasad Akku

http://www.w3.org/2001/XMLSchema#string

Yogesh Belagali

http://www.w3.org/2001/XMLSchema#string

P2860

A phase 2 study of bortezomib in relapsed, refractory myeloma.

A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma.

Randomized phase III study of pegylated liposomal doxorubicin plus bortezomib compared with bortezomib alone in relapsed or refractory multiple myeloma: combination therapy improves time to progression.

Bortezomib in multiple myeloma: systematic review and clinical considerations.

Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma.

Generic atorvastatin and health care costs.

The cost-effectiveness of initial treatment of multiple myeloma in the U.S. with bortezomib plus melphalan and prednisone versus thalidomide plus melphalan and prednisone or lenalidomide plus melphalan and prednisone with continuous lenalidomide mai

Economic and clinical impact of multiple myeloma to managed care.

Efficacy of bortezomib as first-line treatment for patients with multiple myeloma.

Therapeutic advancements in multiple myeloma.

P304

243

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FONC.2016.00243

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27917369

http://www.w3.org/2001/XMLSchema#string

P921

An Ucràin

India

P932

5117112

http://www.w3.org/2001/XMLSchema#string